Skip to content

Medical-device intelligence

PJI: Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System

FDA product code PJI: Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PJI
FDA device name
Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System
Device class
2
Regulation number
866.5930
Medical specialty
Immunology
Review panel
IM

FDA definition

A newborn screening test for severe combined immunodeficiency (SCID) intended for the detection of T-cell receptor excision circle (TREC) genomic DNA isolated from newborn blood specimens dried on filter paper. It is intended as an aid in screening newborns for severe combined immunodeficiency (SCID).
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

1 clearance records and 1 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Dec 5, 2016 to Nov 9, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
Eonis SCID-SMA kitK203035 · PJIPerkinelmer, Inc.510(k)Nov 9, 2022FDA decision date
EnLite Neonatal TREC Kit;an in vitro diagnostic device intended for the semi-quantitative determination of TREC (T-cell receptor excision circle)…Z-0897-2017 · PJIPerkinElmer Health Sciences, Inc.RecallDec 22, 2016FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗